|
1
|
No authors listed. Gestational
hypertension and preeclampsia: ACOG practice bulletin, number 222.
Obstet Gynecol. 135:e237–e260. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Shen XY, Zheng LL, Huang J, Kong HF, Chang
YJ, Wang F and Xin H: CircTRNC18 inhibits trophoblast cell
migration and epithelial-mesenchymal transition by regulating
miR-762/Grhl2 pathway in pre-eclampsia. RNA Biol. 16:1565–1573.
2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
E Davies J, Pollheimer J, Yong HE,
Kokkinos MI, Kalionis B, Knofler M and Murthi P:
Epithelial-mesenchymal transition during extravillous trophoblast
differentiation. Cell Adh Migr. 10:310–321. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
DaSilva-Arnold SC, Zamudio S, Al-Khan A,
Alvarez-Perez J, Mannion C, Koenig C, Luke D, Perez AM, Petroff M,
Alvarez M, et al: Human trophoblast epithelial-mesenchymal
transition in abnormally invasive placenta. Biol Reprod.
99:409–421. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Moldovan L, Batte KE, Trgovcich J, Wisler
J, Marsh CB and Piper M: Methodological challenges in utilizing
miRNAs as circulating biomarkers. J Cell Mol Med. 18:371–390.
2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Cai Z, Li J, Zhuang Q, Zhang X, Yuan A,
Shen L, Kang K, Qu B, Tang Y, Pu J, et al: MiR-125a-5p ameliorates
monocrotaline-induced pulmonary arterial hypertension by targeting
the TGF-β1 and IL-6/STAT3 signaling pathways. Exp Mol Med. 50:1–11.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shi J, Zhang Y, Jin N, Li Y, Wu S and Xu
L: MicroRNA-221-3p plays an oncogenic role in gastric carcinoma by
inhibiting PTEN expression. Oncol Res. 25:523–536. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Peng H, Pan X, Su Q, Zhu LS and Ma GD:
MiR-372-3p promotes tumor progression by targeting LATS2 in
colorectal cancer. Eur Rev Med Pharmacol Sci. 23:8332–8344.
2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen DB and Wang W: Human placental
microRNAs and preeclampsia. Biol Reprod. 88(130)2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lv Y, Lu X, Li C, Fan Y, Ji X, Long W,
Meng L, Wu L, Wang L, Lv M and Ding H: miR-145-5p promotes
trophoblast cell growth and invasion by targeting FLT1. Life Sci.
239(117008)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Brkić J, Dunk C, O'Brien J, Fu G, Nadeem
L, Wang YL, Rosman D, Salem M, Shynlova O, Yougbaré I, et al:
MicroRNA-218-5p promotes endovascular trophoblast differentiation
and spiral artery remodeling. Mol Ther. 26:2189–2205.
2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yang Y, Li H, Ma Y, Zhu X, Zhang S and Li
J: MiR-221-3p is down-regulated in preeclampsia and affects
trophoblast growth, invasion and migration partly via targeting
thrombospondin 2. Biomed Pharmacother. 109:127–134. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tayyar AT, Karakus R, Eraslan Sahin M,
Topbas NF, Sahin E, Karakus S, Yalcin ET and Tayyar A: Wnt
signaling pathway in early- and late-onset preeclampsia: Evaluation
with Dickkopf-1 and R-Spondin-3 glycoproteins. Arch Gynecol Obstet.
299:1551–1556. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
von Dadelszen P, Magee LA and Roberts JM:
Subclassification of preeclampsia. Hypertens Pregnancy. 22:143–148.
2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Herzog EM, Eggink AJ, Reijnierse A,
Kerkhof MA, de Krijger RR, Roks AJ, Reiss IK, Nigg AL, Eilers PH,
Steegers EA, et al: Impact of early- and late-onset preeclampsia on
features of placental and newborn vascular health. Placenta.
49:72–79. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cim N, Kurdoglu M, Ege S, Yoruk I, Yaman G
and Yildizhan R: An analysis on the roles of angiogenesis-related
factors including serum vitamin D, soluble endoglin (sEng), soluble
fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth
factor (VEGF) in the diagnosis and severity of late-onset
preeclampsia. J Matern Fetal Neonatal Med. 30:1602–1607.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Karreth FA and Pandolfi PP: ceRNA
cross-talk in cancer: When ce-bling rivalries go awry. Cancer
Discov. 3:1113–1121. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yang R, Xing L, Zheng X, Sun Y, Wang X and
Chen J: The circRNA circAGFG1 acts as a sponge of miR-195-5p to
promote triple-negative breast cancer progression through
regulating CCNE1 expression. Mol Cancer. 18(4)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Beermann J, Piccoli MT, Viereck J and Thum
T: Non-coding RNAs in development and disease: Background,
mechanisms, and therapeutic approaches. Physiol Rev. 96:1297–1325.
2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lee CT, Risom T and Strauss WM:
Evolutionary conservation of microRNA regulatory circuits: An
examination of microRNA gene complexity and conserved
microRNA-target interactions through metazoan phylogeny. DNA Cell
Biol. 26:209–218. 2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gantier MP, McCoy CE, Rusinova I, Saulep
D, Wang D, Xu D, Irving AT, Behlke MA, Hertzog PJ, Mackay F and
Williams BR: Analysis of microRNA turnover in mammalian cells
following Dicer1 ablation. Nucleic Acids Res. 39:5692–5703.
2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sayed AS, Xia K, Salma U, Yang T and Peng
J: Diagnosis, prognosis and therapeutic role of circulating miRNAs
in cardiovascular diseases. Heart Lung Circ. 23:503–510.
2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sur S, Steele R, Shi X and Ray RB:
miRNA-29b inhibits prostate tumor growth and induces apoptosis by
increasing bim expression. Cells. 8(1455)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ghafouri-Fard S, Shoorei H and Taheri M:
miRNA profile in ovarian cancer. Exp Mol Pathol.
113(104381)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hromadnikova I, Kotlabova K, Ivankova K,
Vedmetskaya Y and Krofta L: Profiling of cardiovascular and
cerebrovascular disease associated microRNA expression in umbilical
cord blood in gestational hypertension, preeclampsia and fetal
growth restriction. Int J Cardiol. 249:402–409. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhao G, Zhou X, Chen S, Miao H, Fan H,
Wang Z, Hu Y and Hou Y: Differential expression of microRNAs in
decidua-derived mesenchymal stem cells from patients with
pre-eclampsia. J Biomed Sci. 21(81)2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhou C, Zou QY, Li H, Wang RF, Liu AX,
Magness RR and Zheng J: Preeclampsia downregulates MicroRNAs in
fetal endothelial cells: Roles of miR-29a/c-3p in endothelial
function. J Clin Endocrinol Metab. 102:3470–3479. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wang Q, Liu S, Zhao X, Wang Y, Tian D and
Jiang W: MiR-372-3p promotes cell growth and metastasis by
targeting FGF9 in lung squamous cell carcinoma. Cancer Med.
6:1323–1330. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li Y, Liu JJ, Zhou JH, Chen R and Cen CQ:
LncRNA HULC induces the progression of osteosarcoma by regulating
the miR-372-3p/HMGB1 signalling axis. Mol Med.
26(26)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Fan J, Zhang J, Huang S and Li P: lncRNA
OSER1-AS1 acts as a ceRNA to promote tumorigenesis in
hepatocellular carcinoma by regulating miR-372-3p/Rab23 axis.
Biochem Biophys Res Commun. 521:196–203. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Soliman MH, Ragheb MA, Elzayat EM, Mohamed
MS, El-Ekiaby N, Abdelaziz AI and Abdel-Wahab AA: MicroRNA-372-3p
predicts response of TACE patients treated with doxorubicin and
enhances chemosensitivity in hepatocellular carcinoma. Anticancer
Agents Med Chem. 21:246–253. 2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Fan X, Huang X, Li Z and Ma X:
MicroRNA-372-3p promotes the epithelial-mesenchymal transition in
breast carcinoma by activating the Wnt pathway. J BUON.
23:1309–1315. 2018.PubMed/NCBI
|
